1 DESCOVY (EMTRICITABINE/TENOFOV ALAFENAM) | 50 of 270 | 730 prescriptions Less than 1% of all prescriptions | | 160 patients 22% of all patients | < 11 | |
2 PRAVASTATIN SODIUM | 1290 of 9180 | 490 prescriptions Less than 1% of all prescriptions | | 120 patients 16% of all patients | < 11 | |
3 GENVOYA (ELVITEG/COB/EMTRI/TENOF ALAFEN) | 110 of 280 | 590 prescriptions Less than 1% of all prescriptions | | 120 patients 16% of all patients | < 11 | |
4 RITONAVIR | 30 of 160 | 440 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
5 ATRIPLA (EFAVIRENZ/EMTRICIT/TENOFOVR DF) | 20 of 160 | 500 prescriptions Less than 1% of all prescriptions | | 110 patients 15% of all patients | < 11 | |
6 OMEPRAZOLE | 2200 of 1,2280 | 400 prescriptions Less than 1% of all prescriptions | | 110 patients 15% of all patients | < 11 | |
7 TIVICAY (DOLUTEGRAVIR SODIUM) | 120 of 290 | 460 prescriptions Less than 1% of all prescriptions | | 120 patients 16% of all patients | < 11 | |
8 PREZISTA (DARUNAVIR ETHANOLATE) | 110 of 210 | 410 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 LISINOPRIL | 2450 of 1,4520 | 390 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 HYDROCHLOROTHIAZIDE | 1560 of 1,0900 | 180 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
11 GABAPENTIN | 2450 of 1,4660 | 270 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
12 ACYCLOVIR | 150 of 1020 | 240 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
13 LAMIVUDINE | 40 of 100 | 260 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 PREZCOBIX (DARUNAVIR/COBICISTAT) | 100 of 210 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 SERTRALINE HCL | 1330 of 9010 | 210 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
16 ATAZANAVIR SULFATE | 30 of 80 | 220 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
17 ATENOLOL | 820 of 6130 | 140 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
18 ISENTRESS (RALTEGRAVIR POTASSIUM) | 110 of 170 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 TRIUMEQ (ABACAVIR/DOLUTEGRAVIR/LAMIVUDI) | 110 of 200 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 TRUVADA (EMTRICITABINE/TENOFOVIR (TDF)) | 90 of 180 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 ABACAVIR (ABACAVIR SULFATE) | 60 of 110 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 LIVALO (PITAVASTATIN CALCIUM) | 60 of 220 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 TAMSULOSIN HCL | 1200 of 6840 | 140 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
24 BIKTARVY (BICTEGRAV/EMTRICIT/TENOFOV ALA) | 60 of 130 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 CITALOPRAM HBR (CITALOPRAM HYDROBROMIDE) | 1240 of 8190 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 ODEFSEY (EMTRICITAB/RILPIVIRI/TENOF ALA) | 80 of 150 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 FENOFIBRATE (FENOFIBRATE NANOCRYSTALLIZED) | 490 of 2700 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
28 VALACYCLOVIR (VALACYCLOVIR HCL) | 260 of 2090 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
29 TENOFOVIR DISOPROXIL FUMARATE | 60 of 70 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
30 ISENTRESS HD (RALTEGRAVIR POTASSIUM) | 20 of 20 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |